| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 08/07/2003 | CA2474451A1 Cycloalkyl inhibitors of potassium channel function |
| 08/07/2003 | CA2474339A1 Multiple virus replicon culture systems |
| 08/07/2003 | CA2473984A1 Metabolites of (3-{[4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino]-methyl}-phenoxy)-acetic acid |
| 08/06/2003 | EP1332146A2 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 08/06/2003 | EP1117648B1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 08/06/2003 | EP1090022B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives |
| 08/06/2003 | EP1083934B1 EGR-1 for the manufacture of a medicament for treating wounds |
| 08/06/2003 | EP0906086B1 Skin wash composition |
| 08/06/2003 | CN1434832A DNA for encoding the RGI polypeptide |
| 08/06/2003 | CN1434830A 2-aminocarbonyl-9H-punine derivatives |
| 08/06/2003 | CN1434821A Quinazoline derivatives for the treatment of tumours |
| 08/06/2003 | CN1434802A New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias |
| 08/06/2003 | CN1434717A Medicine for treating obesity and method of producing and use thereof |
| 08/06/2003 | CN1434699A Hair bleaching and colouring compositions having a PH greater than PH 10 comprising cholesterol |
| 08/06/2003 | CN1117092C Azadicyclic compound, its medicinal composition and medicinal use |
| 08/05/2003 | US6602866 Mercaptoacetylamide derivatives, a process for their preparation and their use |
| 08/05/2003 | US6602525 Compositions comprising nitrofurantoin and uva ursi |
| 08/05/2003 | US6602303 And a combination of an alkoxylated or glycerolated fatty alcohol and a hydroxylated |
| 07/31/2003 | WO2003062279A1 Nutraceuticals for the treatment, protection and restoration of connective tissues |
| 07/31/2003 | WO2003061652A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| 07/31/2003 | WO2003061580A2 Alteration of rab38 function to modulate mammalian pigmentation |
| 07/31/2003 | WO2003061561A2 Epsilon immunoglobulin chain derived peptides for induction of anti-ige antibodies |
| 07/31/2003 | WO2003061553A2 An extract of acanthopanax koreanum for the treatment or prevention of hepatitis or the liver protective drug |
| 07/31/2003 | WO2003047516A3 Pyrimidine compounds |
| 07/31/2003 | WO2003037253A3 Methods for the treatment and diagnosis of tumorigenic and angiogenic disorders using 32616 |
| 07/31/2003 | WO2002060875A8 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes |
| 07/31/2003 | WO2002034211A3 Antiperspirant salts for enhanced cosmetic products |
| 07/31/2003 | WO2002024909A3 Receptor nucleic acids and polypeptides |
| 07/31/2003 | US20030144305 Novel compounds |
| 07/31/2003 | US20030144263 Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them |
| 07/31/2003 | US20030143250 Pharmaceutical compositions comprising cyclosporins |
| 07/31/2003 | US20030143163 For therapy of respiratory disorders; aerosol formulations of use for the administration of medicaments by inhalation |
| 07/31/2003 | CA2474269A1 Nutraceuticals for the treatment, protection and restoration of connective tissues |
| 07/31/2003 | CA2473474A1 Alteration of rab38 function to modulate mammalian pigmentation |
| 07/31/2003 | CA2472238A1 3-(imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors |
| 07/30/2003 | EP1331007A2 Chinese herbs extract |
| 07/30/2003 | EP1330293A2 Controlled release composition comprising lactic acid polymer and hydroxynaphthoic acid, and method of producing the same |
| 07/30/2003 | EP1330263A2 Method for down-regulating ige |
| 07/30/2003 | EP1330249A1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 07/30/2003 | CN1433416A N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl] carboxamideinhibitors of cyclin dependent kinases |
| 07/30/2003 | CN1433412A Novel tetrahydropyridines, preparation method and pharmaceutical compositions containing same |
| 07/30/2003 | CN1433313A Combination of serotonin reuptake inhibitor and 5-HT2C antagonist, inverse agonist or partial agonist |
| 07/30/2003 | CN1433294A Ceramic material for dental applications and method for production thereof |
| 07/30/2003 | CN1116270C Novel retinoids derivs. |
| 07/29/2003 | US6600047 Substantially free from amlodipine aspartate side products, by reacting amlodipine or an acid addition salt thereof with excess maleic acid under acidic environment |
| 07/29/2003 | US6599905 Pyrazine compounds |
| 07/29/2003 | CA2172159C Improved pharmaceutical formulation |
| 07/29/2003 | CA2078379C Method of treating immunoinflammatory disease |
| 07/29/2003 | CA2069481C Purified igc immunoglobulins |
| 07/24/2003 | WO2003060090A2 Novel cytokine zcytor17 ligand |
| 07/24/2003 | WO2003059880A1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/24/2003 | WO2003059807A2 Crystalline solids of carvedilol and processes for their preparation |
| 07/24/2003 | WO2003059292A2 Composition and method for maintaining non-enveloped viral vectors |
| 07/24/2003 | US20030139605 Antiproliferative agents, treating or preventing osteoporosis, inflammation, and angiogenesis disorders, treating liver cancer |
| 07/24/2003 | US20030139424 Dietetic therapy |
| 07/24/2003 | US20030139384 Transdermal supplying testosterone |
| 07/24/2003 | US20030139340 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (TFPI) |
| 07/24/2003 | US20030139339 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor ( TFPI) |
| 07/24/2003 | US20030138404 Interferon antagonists useful for the treatment of interferon related diseases |
| 07/24/2003 | CA2472377A1 Crystalline solids of carvedilol and processes for their preparation |
| 07/23/2003 | EP1328320A2 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 07/23/2003 | EP1328284A1 Novel medicinal herbal composition for treating liver diseases and hiv |
| 07/23/2003 | EP1328264A1 Use of estramustine phosphate in the treatment of bone metastasis |
| 07/23/2003 | EP1075259B1 Novel fatty analogues for the treatment of diabetes |
| 07/23/2003 | EP1073445B1 Substance mixture for topical application comprising olive oil and honey |
| 07/23/2003 | CN1432010A 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroi-soquinol-2-yl)-5-(2-pyridyl) quinazo line mesylat and polymorphs |
| 07/23/2003 | CN1431901A S-methyl-dihydro-zipprasidone for treatment of psychiatric and ocular disorders |
| 07/23/2003 | CN1115165C Externally applied medicated wine for treating traumatic injury and rheumatism |
| 07/23/2003 | CN1115152C Method for treating bronchitis with uridine triphosphates and related compounds |
| 07/22/2003 | USRE38200 Indole-2,3-dione-3-oxime derivatives |
| 07/22/2003 | US6596763 Method for counteracting infections caused by bacteria, fungi or virus such as Herpes Simplex Virus in skin or mucosal membranes, in particular genital membranes, of a mammal. The method comprises topically administering to skin or mucous |
| 07/22/2003 | US6596737 C10 carbamoyloxy substituted taxanes |
| 07/22/2003 | US6596719 6 alkoxy-4-pyrimidinyl bis-sulfonamides |
| 07/22/2003 | US6596313 Nutritional supplement and methods of using it |
| 07/22/2003 | US6596283 Chemically-modified group B polysaccharides of Neisseria meningitidis for use as vaccines |
| 07/22/2003 | CA2353693C Pharmaceutical composition containing citalopram |
| 07/17/2003 | WO2003057133A2 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 07/17/2003 | WO2003003987A3 Solid phase synthesis of arylretinamides |
| 07/17/2003 | US20030134878 Use of a compound in providing refreshedness on waking and a method for the treatment of drowsiness therewith |
| 07/17/2003 | US20030134844 Nicontinic acetylcholine receptor antagonists in the treatment of restless legs syndrome |
| 07/17/2003 | US20030134833 Substance for lowering high cholesterol level in serum and methods for preparing and using the same |
| 07/17/2003 | US20030134804 Rehydrating formulation |
| 07/17/2003 | US20030134800 Physiologically active substance in high content, suppressing the initial excess release, and achieving a stable release speed over a long period of time is provided. composition weight, (2) hydroxynaphthoic acid |
| 07/17/2003 | US20030133964 Polymeric delivery formulations of leuprolide with improved efficacy |
| 07/17/2003 | CA2471490A1 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 07/16/2003 | EP1327451A1 Adjuvants for vaccines |
| 07/16/2003 | EP1327446A1 Controlled release oxycodone compositions |
| 07/16/2003 | EP1327445A1 Controlled release oxycodone compositions |
| 07/16/2003 | EP1326867A2 Bridged piperazine derivatives |
| 07/16/2003 | EP1326633A1 Composition comprising immunogenic microparticles |
| 07/16/2003 | EP1155000B1 2-aminopyridines containing fused ring substituents |
| 07/16/2003 | EP1084104B1 Nitric oxide synthase inhibitors |
| 07/16/2003 | EP1070069B1 Bicyclic hydroxamic acid derivatives |
| 07/16/2003 | CN1430515A Divided dose therapies with vascular damaging activity |
| 07/16/2003 | CN1430504A Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into biological environmentat from polymer matrix |
| 07/16/2003 | CN1114597C Quinoline derivs |
| 07/16/2003 | CN1114592C Crystalline forms of osanetant |
| 07/16/2003 | CN1114401C Use of 11-(3-dimethylaminoprpylidene)-6,11-dihydrodibenz [b,e] oxepin-2-acetic acid for manufacture of medicament |
| 07/15/2003 | US6593360 The invention relates to novel 15-membered 8a- and 9a-lactams from the class of 6-O-methyl-erythromycin A of general formula their pharmaceutically acceptable addition salts with inorganic or organic acids and their hydrates, to |
| 07/15/2003 | US6593330 Compounds and their use |